Gyre Therapeutics
GYRE
GYRE
75 hedge funds and large institutions have $95.2M invested in Gyre Therapeutics in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.17% less ownership
Funds ownership: 10.27% → 9.1% (-1.2%)
60% less capital invested
Capital invested by funds: $236M → $95.2M (-$141M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
75
Holding in Top 10
1
Calls
$3.75M
Puts
$4.16M
Top Buyers
| 1 | +$7.01M | |
| 2 | +$6.9M | |
| 3 | +$6.42M | |
| 4 |
NC
Nexthera Capital
New York
|
+$2.9M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.87M |
Top Sellers
| 1 | -$26.4M | |
| 2 | -$21.4M | |
| 3 | -$14.3M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$13.3M |
| 5 |
SFM
Soros Fund Management
New York
|
-$9.37M |